Meta-analysis of the Prognostic Value of Lymphocyte to Monocyte Ratio (LMR) in Non-metastatic Renal Cell Carcinoma.

NCT04213664 · clinicaltrials.gov ↗

UNKNOWN

Status

4666

Enrollment

OTHER

Sponsor class

Conditions

Renal Cell Carcinoma
Progression
Lymphocyte Disorder
Monocytosis
Local Disease

Interventions

OTHER: prognosis

Sponsor

Corporacion Parc Tauli